About Beckman Coulter
Beckman Coulter is a company based in Brea (United States) founded in 1935 by Arnold O Beckman was acquired by Danaher in February 2011. It operates as a Direct-to-Consumer (D2C) and Professional Services. The company has 1,132 employees as of March 31, 2024. Beckman Coulter has completed 8 acquisitions, including Advalytix AG, Cogenics and Cytobank. Beckman Coulter offers products and services including DxC 500 AU Chemistry Analyzer, DxI 9000 Immunoassay Analyzer, and DxA 5000 Total Lab Automation. Beckman Coulter operates in a competitive market with competitors including Cepheid, Bruker, Blackrock Neurotech, Esco Lifesciences and Unchained Labs, among others.
- Headquarter Brea, United States
- Employees 1132 as on 31 Mar, 2024
- Founders Arnold O Beckman
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Beckman Coulter, Inc.
- Date of Incorporation 02 Nov, 2005
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
$102.64 M (USD)0.57as on Mar 31, 2021
-
Net Profit
$5.28 M (USD)61.74as on Mar 31, 2021
-
EBITDA
$25.01 M (USD)-3.93as on Mar 31, 2021
-
Latest Funding Round
Not available
-
Investors
Danaher
& 3 more
-
Employee Count
1132
as on Mar 31, 2024
-
Investments & Acquisitions
Advalytix AG
& 7 more
-
Acquired by
Danaher
(Feb 07, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Beckman Coulter
Beckman Coulter offers a comprehensive portfolio of products and services, including DxC 500 AU Chemistry Analyzer, DxI 9000 Immunoassay Analyzer, and DxA 5000 Total Lab Automation.
Used for analyzing chemical components in patient samples.
Employed for detecting specific proteins in blood samples.
Designed to automate laboratory workflows for efficiency gains.
People of Beckman Coulter
Unlock access to complete
Software Development Team
189 people
Sales and Marketing
87 people
Senior Team
67 people
Product Management Team
54 people
Leadership Team
52 people
Staff Team
27 people
Human Resources and Administration
24 people
Operations Team
21 people
Unlock access to complete
Funding Insights of Beckman Coulter
Investors in Beckman Coulter
Beckman Coulter has secured backing from 4 investors, including institutional investors. Prominent investors backing the company include Danaher, European Union and Public Health Emergency.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Innovative health security solutions are funded by BARDA DRIVe.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Beckman Coulter
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Beckman Coulter
Beckman Coulter has strategically engaged in corporate development activities, having acquired 8 companies. Notable acquisitions include Advalytix AG, Cogenics and Cytobank.
Investment portfolio details for Beckman Coulter
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Predictive analytics for hospital administration and patient workflows are provided.
|
Locked | Locked | 2016 | Locked | |
|
Provider of products to measure antibody concentration and host cell stability
|
Locked | Locked | 2014 | Locked | |
|
Flow cytometer research applications are developed for nanoscale object detection.
|
Locked | Locked | 2013 | Locked |
Complete acquisition details for Beckman Coulter
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Beckman Coulter
Detailed financials for Beckman Coulter
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Beckman Coulter Comparisons
Peer comparison for Beckman Coulter
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Beckman Coulter
Beckman Coulter operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cepheid, Bruker, Blackrock Neurotech, Esco Lifesciences and Unchained Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of molecular diagnostic testing solutions
|
|
| Locked | Locked | Locked |
Diversified research instrument systems are manufactured and supplied.
|
|
| Locked | Locked | Locked |
Medical devices for neurological therapies are developed.
|
|
| Locked | Locked | Locked |
Manufacturer of biopharma equipment & IVF medical devices, and service provider for life science tools
|
|
| Locked | Locked | Locked |
Multiplex protein stability platform for biologics is developed.
|
Detailed competitors of Beckman Coulter
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Beckman Coulter
Complete news archive for Beckman Coulter
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Beckman Coulter
Beckman Coulter was founded in 1935 and raised its 1st funding round 79 years after it was founded.
Beckman Coulter is headquartered in Brea, United States. It is registered at Brea, California, United States.
J Robert Hurley is the current CEO of Beckman Coulter.
As of Mar 31, 2024, the latest employee count at Beckman Coulter is 1,132.
Annual revenue of Beckman Coulter is $102.64M as on Mar 31, 2021.
Beckman Coulter is involved in the development and provision of diagnostic solutions for clinical laboratories worldwide. The company focuses on areas such as chemistry, immunoassay, hematology, urinalysis, microbiology, and blood banking. Innovative products and automation systems are offered to enhance laboratory workflows and improve patient care outcomes. Solutions are provided for critical health issues including antimicrobial resistance, infectious diseases, cardiovascular disease, diabetes, and neurology. Through advanced diagnostics and digital tools, clinical decision-making is supported across various healthcare settings.
Beckman Coulter's top competitors include Cepheid, Blackrock Neurotech and Esco Lifesciences.
Beckman Coulter offers DxC 500 AU Chemistry Analyzer, DxI 9000 Immunoassay Analyzer, and DxA 5000 Total Lab Automation.
Beckman Coulter has made 8 acquisitions, including Advalytix AG, Cogenics, and Cytobank.
Beckman Coulter has 4 investors. Key investors include Danaher, European Union, Public Health Emergency, and BARDA DRIVe.